Anna Aillerie

Head of Commercial Operations, Biotechnology at Gedeon Richter

Over more than 20 years, Anna Aillerie has been involved with strategic marketing, global launch management and portfolio management for well-known companies like Lipha, Merck KgaA, Merck Generics, Mylan, Lupin and Gedeon Richter.

Anna has extensively worked on a diverse set of assignments to acquire valuable experience in marketing, portfolio and project management from both big pharma, as well as generics perspective. She holds a Master of Sciences in Pharmaceutical and Healthcare Marketing from the University Paris VI, and is currently responsible for developing biosimilar commercial activities in her role as Head of Commercial Operations, Biotechnology at Gedeon Richter.


Title: Challenges and opportunities in development of Biosimilars: Global Perspective

  • Exhaustive information about new products, untapped geographies, recent developments, and investments in the biosimilars market
  • New guidance from FDA to help manufacturers develop more treatment options